COPD is the second most common cause of emergency admissions to hospital.
Attend2 COPD is underpinned by national and international guidelines (including the GOLD report and NICE NG115) and is used to identify patients who may benefit from a review of their current management strategy.
The service can be used to support the management of patients with COPD, highlighting patients missing key records such as annual reviews, symptom scores (MRC or CAT), exacerbation counts and pulmonary rehab status, prioritising them based on the burden of illness.
Attend2 COPD stratifies COPD patients, taking into account a patient’s current level of symptoms & exacerbations, treatments and co-morbidities as well as other risk factors (e.g. smoking status). Stratifying patients according to the level of clinical need allows practices to more effectively plan and prioritise their workload to optimise patient care.
Action plans can then be drafted, delivering the associated clinical work and measuring outcomes as part of an effective QI cycle in COPD and working to manage the backlog of care as a result of COVID-19.
For all Attend2 platforms purchased with a consultancy day before the 30th of September 2021, we are providing 4 data refreshes free of charge equating to a £400 saving. Data refreshes must be claimed by the 31st of March 2022
An updated Attend2 tool housing refreshed data to help deliver continuing clinical outcomes. A maximum of 4 data refreshes can be delivered across the year.
Tiered pricing
Our Clinical Pharmacists are now able to offer coding support across a number of QOF domains